FY15
Assets4,866.30
Net Worth3,097.10
Total Debt1,074.30
RevenueAnnualised basis3,182.90
EBITDAAnnualised basis593.70
PATAnnualised basis438.80
EBITDA Margin (%)18.65
At a glance
Updated 2026-09-29Alkem Laboratories is an IPO with an issue size of ₹1,349.61 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹1,349.61 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗PENDINGBidding has not started yet.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets5,118.10₹ Cr · +27.6% vs prior year
Net Worth3,468.60₹ Cr · +50.6% vs prior year
FY14
Assets4,201.50
Net Worth2,714.90
Total Debt899.10
RevenueAnnualised basis2,672.90
EBITDAAnnualised basis563.10
PATAnnualised basis440.20
EBITDA Margin (%)21.07
FY13
Assets4,011.20
Net Worth2,302.60
Total Debt1,185.90
RevenueAnnualised basis2,300.90
EBITDAAnnualised basis597.10
PATAnnualised basis466.70
EBITDA Margin (%)25.95
30-Sep-15
Assets5,118.10
Net Worth3,468.60
Total Debt872.20
RevenueAnnualised basis2,059.60
EBITDAAnnualised basis490.20
PATAnnualised basis414.70
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Alkem Laboratories IPO | — | 28.00 x | — | — |
| Symbiotec Pharmalab IPO | — | 61.88 x | — | — |
| Sai Parenteral's IPO | — | 111.58 x | — | — |
| Corona Remedies IPO | — | 35.15 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-29.
IPO UPDATE ALERTS
Register for IPO Updates →Track Alkem Laboratories without missing an update
Register for subscription, GMP, allotment and listing notifications.